GlennBeauty Urea With Metformin in the Short Term to Strengthen Both the Efficacy and Safety Analysis for Type 2 Diabetes
Objective To study the Glenn beauty urea with metformin in the short term to strengthen both the efficacy and safety of type 2 diabetes. Methods From January 2015 to November 2016 first diagnosis in patients with type 2 diabetes, 106 cases were randomly divided into two groups. Group A with normal diet and exercise intervention, such as beauty and oral Glenn urea treatment, B group on the basis of A set of combined therapy with metformin, A total of 12 weeks of treatment. Compare two groups of patients with low blood sugar, liver and kidney and the incidence of gastrointestinal adverse reactions;Blood glucose control is at the time; Performed before and after treatment patients ' blood sugar levels, differences in insulin secretion, insulin resistance index. Results Two groups of patients with low blood sugar, liver and kidney, and no significant difference in incidence of gastrointestinal adverse reactions, P>0. 05; Blood glucose control is at target group B was shorter than group A, P < 0. 05; Before implementation of treatment two groups of blood glucose, insulin secretion, insulin resistance index was no significant difference, P > 0. 05; Implementation of group B blood glucose levels after treatment, insulin secretion, insulin resistance index has improved more, P<0. 05 ) . Conclusion Craig beauty urea with metformin in the short term to strengthen both the efficacy and safety of type 2 diabetes, which can effectively improve the patients' blood sugar levels and insulin secretion, low risk of hypoglycemia, safe and reliable, is worth promoting.
glenn beautiful ureametforminthe short-term intensie treatmentfirst diagnosis of type 2 diabetescurative effectsecurity
NETL
NSTL
万方数据
维普
